Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction

JACC. Basic to Translational Science
Muhammad AliJohn W Chen

Abstract

PF-1355 is an oral myeloperoxidase (MPO) inhibitor that successfully decreased elevated MPO activity in mouse myocardial infarction models. Short duration PF-1355 treatment for 7 days decreased the number of inflammatory cells and attenuated left ventricular dilation. Cardiac function and remodeling improved when treatment was increased to 21 days. Better therapeutic effect was further achieved with early compared with delayed treatment initiation (1 h vs. 24 h after infarction). In conclusion, PF-1355 treatment protected a mouse heart from acute and chronic effects of MI, and this study paves the way for future translational studies investigating this class of drugs in cardiovascular diseases.

References

Jun 8, 1999·The Journal of Clinical Investigation·E A PodrezS L Hazen
Nov 22, 2001·JAMA : the Journal of the American Medical Association·R ZhangS L Hazen
Sep 4, 2003·Circulation·Stephan BaldusUNKNOWN CAPTURE Investigators
Oct 24, 2003·The New England Journal of Medicine·Marie-Luise BrennanStanley L Hazen
Aug 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·Constanze BergtJay W Heinecke
Feb 4, 2005·Journal of Leukocyte Biology·Seymour J Klebanoff
Mar 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Stephen J Nicholls, Stanley L Hazen
Jun 24, 2005·The New England Journal of Medicine·Scott D SolomonUNKNOWN Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators
Jun 19, 2007·Journal of the American College of Cardiology·W H Wilson TangAllan L Klein
Jun 27, 2007·British Journal of Pharmacology·E MalleC Obinger
Sep 15, 2007·Free Radical Biology & Medicine·Volker RudolphStephan Baldus
Nov 21, 2007·The Journal of Experimental Medicine·Matthias NahrendorfMikael J Pittet
Oct 29, 2008·Circulation·Raghava S VelagaletiRamachandran S Vasan
Nov 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michael O BreckwoldtRalph Weissleder
Nov 21, 2008·Cardiovascular Research·Ulf LandmesserHelmut Drexler
Jun 27, 2009·Clinical Chemistry·Roger K SchindhelmPeter G Scheffer
Apr 10, 2010·Journal of the American College of Cardiology·Peter PanizziMatthias Nahrendorf
Jun 26, 2010·The Journal of Clinical Investigation·Filip K SwirskiMatthias Nahrendorf
Oct 29, 2010·Blood·Anna KlinkeStephan Baldus
Jan 12, 2013·Science·Filip K Swirski, Matthias Nahrendorf
Jul 19, 2013·PloS One·Benjamin PulliJohn W Chen
Jan 17, 2014·Science Translational Medicine·Lester Kobzik, Filip K Swirski
Feb 24, 2015·The Journal of Pharmacology and Experimental Therapeutics·Wei ZhengLeonard Buckbinder

❮ Previous
Next ❯

Citations

Mar 3, 2019·Cardiovascular Research·Ioanna AndreadouDerek J Hausenloy
Feb 7, 2019·Cardiovascular Research·Inbar Raber, Aarti Asnani
Mar 20, 2019·PloS One·Rachel J Roth FlachLeonard Buckbinder
Sep 22, 2020·Circulation Research·Adele L RichartBronwyn A Kingwell
Apr 28, 2017·International Journal of Molecular Sciences·Francesco Mariani, Luca Roncucci
Aug 16, 2018·MedChemComm·Franck DuclosEllen K Kick
Dec 14, 2018·Basic Research in Cardiology·Mira JungThomas Thum
Apr 30, 2019·Frontiers in Cardiovascular Medicine·Shuang ZhangEdward B Thorp
Dec 19, 2019·Antioxidants & Redox Signaling·Chrishan J A RamachandraDerek J Hausenloy
Apr 21, 2018·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Hyeon J KimJohn W Chen
May 28, 2019·Proceedings of the National Academy of Sciences of the United States of America·Cuihua WangJohn W Chen
Dec 28, 2019·Journal of the American Society of Nephrology : JASN·Marilina AntonelouUNKNOWN RAVE-ITN Investigators
Apr 3, 2019·Frontiers in Cardiovascular Medicine·Sarah-Lena Puhl, Sabine Steffens
Oct 8, 2020·Journal of Cardiovascular Pharmacology·Youming ZhangHaibo Liu
Oct 13, 2020·Frontiers in Physiology·Toby P Thomas, Laurel A Grisanti
Oct 22, 2020·International Journal of Molecular Sciences·Mary El KazziPaul K Witting
Dec 3, 2020·Biomedicines·Andrea Bonnin MárquezEmiel P.C. van der Vorst
Dec 22, 2020·Frontiers in Cardiovascular Medicine·Albert TopfMichael Lichtenauer
Sep 23, 2020·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Miaomiao WuSherry D Fleming
Mar 9, 2021·Oxidative Medicine and Cellular Longevity·Shuang Ling, Jin-Wen Xu
Dec 4, 2020·Journal of Chemical Information and Modeling·Isaac de Araújo MatosFlavia Carla Meotti
May 5, 2021·Journal of Medicinal Chemistry·Cuihua WangJohn W Chen
May 18, 2021·Frontiers in Cardiovascular Medicine·Niek J PluijmertPaul H A Quax
Sep 18, 2021·Cardiovascular Research·Sreejit GopalkrishnaPrabhakara R Nagareddy
Nov 1, 2021·Toxicological Sciences : an Official Journal of the Society of Toxicology·Igor N ZelkoSanjay Srivastava

❮ Previous
Next ❯

Methods Mentioned

BETA
antibody capture assay
Flow cytometry

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.